Australian Gonococcal Surveillance Program, 1 October to 31 December 2025
Monica Lahra1, Siobhan Hurley2, Sebastiaan Van Hal3
1NSW Health Pathology, The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Australia. monica.lahra@health.nsw.gov.au.
Communicable Diseases Intelligence (2018)
|June 15, 2026
Summary
The Australian Gonococcal Surveillance Programme (AGSP) monitors Neisseria gonorrhoeae antimicrobial resistance across Australia. This report details resistance data from October to December 2025, crucial for guiding treatment strategies.
Area of Science:
- Microbiology
- Public Health Surveillance
- Infectious Diseases
Background:
- Neisseria gonorrhoeae causes gonorrhoea, a significant sexually transmitted infection.
- Antimicrobial resistance in N. gonorrhoeae poses a major global health threat.
- The Australian National Neisseria Network (NNN) coordinates national surveillance efforts.
Purpose of the Study:
- To present the national gonococcal antimicrobial resistance surveillance data for the fourth quarter of 2025.
- To inform public health responses and clinical management of gonorrhoea in Australia.
Main Methods:
- Data collection through a network of reference laboratories across Australian states and territories.
- Antimicrobial susceptibility testing performed on N. gonorrhoeae isolates.
- Reporting of data to the Australian Gonococcal Surveillance Programme (AGSP).
Main Results:
- The report covers surveillance data from 1 October to 31 December 2025.
- Data are presented in quarterly and annual formats.
- Specific antimicrobial resistance trends will be detailed in the full report.
Conclusions:
- Continued surveillance is essential for tracking antimicrobial resistance patterns.
- Timely data dissemination supports effective gonorrhea control strategies.
- Monitoring resistance is vital for maintaining treatment efficacy.
Related Concept Videos
01:26Principles of Disease Surveillance
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
01:27Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...